This inventor holds 1 USPTO granted patent. Top assignee: The University of British Columbia. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Wendy Bolvin: Innovator in Chronic Inflammatory Disease Diagnostics
Introduction
Wendy Bolvin is a prominent inventor based in Coquitlam, Canada. She has made significant contributions to the field of diagnostics, particularly in identifying chronic inflammatory diseases. Her innovative work has the potential to improve patient outcomes through early detection and intervention.
Latest Patents
Wendy Bolvin holds a patent for a method related to Granzyme A and Granzyme B diagnostics. This patent, which is crucial for identifying subjects at risk for or having chronic inflammatory diseases, fibrillinopathy, atherosclerosis, or coronary artery disease, outlines a method that includes determining the concentration of GrA and/or GrB in a blood or serum sample. The method compares these concentrations to those in a control sample, where elevated levels may indicate the presence of these serious health conditions. Additionally, the method may involve identifying concentrations of fibrinogen, elastin, and/or fibrillin.
Career Highlights
Wendy Bolvin is affiliated with the University of British Columbia, where she continues her research and development in the field of diagnostics. Her work is characterized by a commitment to advancing medical science and improving diagnostic techniques.
Collaborations
Wendy collaborates with notable colleagues, including David Granville and Rani Cruz, who contribute to her research efforts and enhance the impact of her work in the scientific community.
Conclusion
Wendy Bolvin's innovative contributions to diagnostics for chronic inflammatory diseases exemplify the importance of research in improving healthcare. Her patent for Granzyme A and Granzyme B diagnostics represents a significant advancement in the field, showcasing her dedication to enhancing patient care through scientific innovation.